BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32408197)

  • 41. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice.
    Foell J; Strahotin S; O'Neil SP; McCausland MM; Suwyn C; Haber M; Chander PN; Bapat AS; Yan XJ; Chiorazzi N; Hoffmann MK; Mittler RS
    J Clin Invest; 2003 May; 111(10):1505-18. PubMed ID: 12750400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN; Minoprio P; Avrameas S; Ternynck T
    Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual Role of Interleukin-10 in Murine NZB/W F1 Lupus.
    Amend A; Wickli N; Schäfer AL; Sprenger DTL; Manz RA; Voll RE; Chevalier N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cells.
    Shao DZ; Yamada S; Hirayama F; Hirano H; Ono S; Hamaoka T
    Immunology; 1995 May; 85(1):16-25. PubMed ID: 7635516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB x NZW F1 mice.
    Suen JL; Wu CH; Chen YY; Wu WM; Chiang BL
    Immunology; 2001 Jul; 103(3):301-9. PubMed ID: 11454059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.
    Bekar KW; Owen T; Dunn R; Ichikawa T; Wang W; Wang R; Barnard J; Brady S; Nevarez S; Goldman BI; Kehry M; Anolik JH
    Arthritis Rheum; 2010 Aug; 62(8):2443-57. PubMed ID: 20506300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proliferation of Ly-1 B cells in autoimmune NZB and (NZB x NZW)F1 mice.
    Wofsy D; Chiang NY
    Eur J Immunol; 1987 Jun; 17(6):809-14. PubMed ID: 2954827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
    Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
    J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.
    Lin W; Seshasayee D; Lee WP; Caplazi P; McVay S; Suto E; Nguyen A; Lin Z; Sun Y; DeForge L; Balazs M; Martin F; Zarrin AA
    Arthritis Rheumatol; 2015 Jan; 67(1):215-24. PubMed ID: 25303150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of coronary vascular disease by transplantation of T-cell-depleted bone marrow and hematopoietic stem cell preparation in autoimmune-prone w/BF(1) mice.
    Kirzner RP; Engelman RW; Mizutani H; Specter S; Good RA
    Biol Blood Marrow Transplant; 2000; 6(5):513-22. PubMed ID: 11063380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibody repertoire analysis in normal and lupus-prone mice.
    Starobinski M; Lacour M; Reininger L; Izui S
    J Autoimmun; 1989 Oct; 2(5):657-74. PubMed ID: 2803476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
    Lettesjö H; Burd GP; Mageed RA
    J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity.
    Shustov A; Luzina I; Nguyen P; Papadimitriou JC; Handwerger B; Elkon KB; Via CS
    J Clin Invest; 2000 Sep; 106(6):R39-47. PubMed ID: 10995792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus.
    Ramanujam M; Wang X; Huang W; Schiffer L; Grimaldi C; Akkerman A; Diamond B; Madaio MP; Davidson A
    J Immunol; 2004 Sep; 173(5):3524-34. PubMed ID: 15322217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extensively re-organized systemic lymph nodes provide a feasible environment for self-reactivity in lupus-prone NZB × NZW F1 mice.
    Kurosawa Y; Ozawa M; Kanda Y; Takeuchi A; Kawamura T; Narita I; Katakai T
    Int Immunol; 2017 Dec; 29(12):567-579. PubMed ID: 29202179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A mimic of p21WAF1/CIP1 ameliorates murine lupus.
    Goulvestre C; Chéreau C; Nicco C; Mouthon L; Weill B; Batteux F
    J Immunol; 2005 Nov; 175(10):6959-67. PubMed ID: 16272356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic association between natural autoantibody responses to histones and DNA in murine lupus.
    Tokushige K; Kinoshita K; Hirose S; Shirai T
    Autoimmunity; 1992; 12(4):285-93. PubMed ID: 1391598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory T cells inhibit autoantigen-specific CD4
    Rosenberger S; Undeutsch R; Akbarzadeh R; Ohmes J; Enghard P; Riemekasten G; Humrich JY
    Front Immunol; 2023; 14():1254176. PubMed ID: 38022661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
    Carlsten H; Holmdahl R; Tarkowski A
    Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.